PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.
PIC Therapeutics has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
PIC Therapeutics's investors include OrbiMed, Lumira Ventures, Advent Life Sciences, Harrington Discovery Institute at University Hospitals, Belinda Termeer.
PIC Therapeutics is headquartered in Natick, United States.
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.
PIC Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PIC Therapeutics — Funding & Investors." VCBacked, October 19, 2022, https://www.vcbacked.co/company/pic-therapeutics. Accessed October 3, 2026.
VCBacked. (2022). PIC Therapeutics — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/pic-therapeutics
{{cite web |title=PIC Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pic-therapeutics |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated